Show simple item record

Glutamate uptake system in the presynaptic vesicle: Glutamic acid analogs as inhibitors and alternate substrates

dc.contributor.authorUeda, Tetsufumien_US
dc.contributor.authorWinter, Harry C.en_US
dc.date.accessioned2006-09-11T16:01:22Z
dc.date.available2006-09-11T16:01:22Z
dc.date.issued1993-01en_US
dc.identifier.citationWinter, Harry C.; Ueda, Tetsufumi; (1993). "Glutamate uptake system in the presynaptic vesicle: Glutamic acid analogs as inhibitors and alternate substrates." Neurochemical Research 18(1): 79-85. <http://hdl.handle.net/2027.42/45406>en_US
dc.identifier.issn0364-3190en_US
dc.identifier.issn1573-6903en_US
dc.identifier.urihttps://hdl.handle.net/2027.42/45406
dc.identifier.urihttp://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=8096630&dopt=citationen_US
dc.description.abstractA variety of naturally occurring amino acids, their isomers, and synthetic analogs were tested for their ability to inhibit uptake of [ 3 H]glutamate into presynaptic vesicles from bovine cerebral cortex. Strongest inhibition (K i <1mM) was observed for trans -1-aminocyclopentane-1,3-dicarboxylic acid (t-ACPD) and erythro -4-methyl-L-glutamic acid (MGlu), while 4-methylene-L-glutamic acid (MeGlu) was only moderately inhibitory (Ki=∼3mM), indicating that the synaptic vesicle glutamate translocator has higher affinity for rans -ACPD and MGlu than for glutamate. A few other amino acids, e.g., 4-hydroxyglutamic acid, S-carboxyethyl cysteine, and 5-fluorotryptophan, were slightly inhibitory; all l - and dl -isomers of protein amino acids and longer chain acidic amino acids were without measurable inhibition. Potassium tetrathionate and S-sulfocysteine exhibited strong to moderate noncompetitive or irreversible inhibition. Inhibition by t-ACPD, MGlu, or MeGlu was competitive with glutamic acid. Each of these competitive inhibitors was also taken up by the vesicle preparation in an ATP-dependent manner, as indicated by their being recovered unchanged from filtered vesicles. Similar results were obtained with reconstituted vesicles, while glutamate uptake by partially purified rat synaptosomes was inhibited only by MGlu. These results indicate that the glutamate translocator of presynaptic vesicles has stringent structural requirements distinct from those of the plasma membrane translocator and the metabotropic type of postsynaptic glutamate receptor. They further suggest possible structural requirements of pharmacologically significant compounds that can substitute for glutamic acid in the presynaptic side of glutamatergic synapses, thus serving to moderate or control glutamate excitation and associated excitotoxic effects in these neurons.en_US
dc.format.extent696838 bytes
dc.format.extent3115 bytes
dc.format.mimetypeapplication/pdf
dc.format.mimetypetext/plain
dc.language.isoen_US
dc.publisherKluwer Academic Publishers-Plenum Publishers; Plenum Publishing Corporation ; Springer Science+Business Mediaen_US
dc.subject.otherGlutamateen_US
dc.subject.otherBiochemistry, Generalen_US
dc.subject.otherNeurosciencesen_US
dc.subject.otherBiomedicineen_US
dc.subject.otherNeurologyen_US
dc.subject.otherSynaptic Vesiclesen_US
dc.subject.otherACPDen_US
dc.subject.otherNeurotransmittersen_US
dc.titleGlutamate uptake system in the presynaptic vesicle: Glutamic acid analogs as inhibitors and alternate substratesen_US
dc.typeArticleen_US
dc.subject.hlbsecondlevelPublic Healthen_US
dc.subject.hlbsecondlevelPsychologyen_US
dc.subject.hlbsecondlevelNeurosciencesen_US
dc.subject.hlbsecondlevelMolecular, Cellular and Developmental Biologyen_US
dc.subject.hlbsecondlevelInternal Medicine and Specialtiesen_US
dc.subject.hlbsecondlevelBiological Chemistryen_US
dc.subject.hlbtoplevelSocial Sciencesen_US
dc.subject.hlbtoplevelScienceen_US
dc.subject.hlbtoplevelHealth Sciencesen_US
dc.description.peerreviewedPeer Revieweden_US
dc.contributor.affiliationumDepartment of Biological Chemistry, Medical School, and Mental Health Research Institute, The University of Michigan, 48109, Ann Arbor, MIen_US
dc.contributor.affiliationumDepartment of Pharmacology, Medical School, and Mental Health Research Institute, The University of Michigan, 48109, Ann Arbor, MI; Mental Health Research Institute, The University of Michigan, 205 Zina Pitcher Place, 48109-0720, Ann Arbor, MIen_US
dc.contributor.affiliationumcampusAnn Arboren_US
dc.identifier.pmid8096630en_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/45406/1/11064_2004_Article_BF00966925.pdfen_US
dc.identifier.doihttp://dx.doi.org/10.1007/BF00966925en_US
dc.identifier.sourceNeurochemical Researchen_US
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.